FCA
TNDM icon

FinTrust Capital Advisors’s Tandem Diabetes Care TNDM Stock Holding History

FinTrust Capital Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,000
Closed -$13K – 1162
2020
Q1 		$13K Buy
+1,000
New +$70.1K 0.01% 714

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FinTrust Capital Advisors's TNDM Position: Q3 2024 in Review

FinTrust Capital Advisors held its Tandem Diabetes Care (TNDM) position steady in Q3 2024 at 712 shares worth $30.2K. The position accounts for 0.01% of the portfolio, ranked #712.

FinTrust Capital Advisors first reported a position in TNDM in Q4 2018 and has held it in 23 quarters since. The position peaked at $299K in Q4 2020. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

  • FinTrust Capital Advisors held 712 shares of Tandem Diabetes Care worth $30.2K as of Q3 2024.
  • FinTrust Capital Advisors left its Tandem Diabetes Care share count unchanged in Q3 2024.
  • Tandem Diabetes Care made up 0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #712 holding.
  • FinTrust Capital Advisors first reported a position in Tandem Diabetes Care in Q4 2018 and has held it in 23 quarters since.
  • FinTrust Capital Advisors's Tandem Diabetes Care position peaked at $299K in Q4 2020.
  • 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.